Evidence map›Paper›PMID 33509206›Full record

ArticleInternational journal for equity in health2021

High prevalence of anti-SARS-CoV-2 IgG antibody in the Xikrin of Bacajá (Kayapó) indigenous population in the brazilian Amazon.

Eliene Putira Sacuema Rodrigues, Isabella Nogueira Abreu, Carlos Neandro Cordeiro Lima, Dennyson Leandro Mathias da Fonseca, Sávio Felipe Gomes Pereira, Laena Costa Dos Reis, Izaura Maria Vieira Cayres Vallinoto, João Farias Guerreiro, Antonio Carlos Rosário Vallinoto

Abstract read
In one paragraph

Article in International journal for equity in health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Socioecology and Prevalence of SARS-CoV-2 Infection in Quilombolas Living in the Brazilian Amazon.American journal of human biology : the official journal of the Human Biology Council · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. The potential for vaccination-induced herd immunity against the SARS-CoV-2 B.1.1.7 variant.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2021
    Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Eliene Putira Sacuema RodriguesLaboratório de Genética Humana e Médica, Instituto de Ciências Biológicas da Universidade Federal do Pará, Belém, PA, Brasil.
Isabella Nogueira AbreuLaboratório de Virologia, Instituto de Ciências Biológicas da Universidade Federal do Pará, Belém, PA, Brasil.
Carlos Neandro Cordeiro LimaLaboratório de Virologia, Instituto de Ciências Biológicas da Universidade Federal do Pará, Belém, PA, Brasil.
Dennyson Leandro Mathias da FonsecaLaboratório de Genética Humana e Médica, Instituto de Ciências Biológicas da Universidade Federal do Pará, Belém, PA, Brasil.
Sávio Felipe Gomes PereiraUniversidade da Amazônia, Belém, Pará, Brasil.
Laena Costa Dos ReisPrograma de Pós-graduação em Enfermagem, Instituto de Ciências da Saúde da Universidade Federal do Pará, Belém, PA, Brasil.
Izaura Maria Vieira Cayres VallinotoLaboratório de Virologia, Instituto de Ciências Biológicas da Universidade Federal do Pará, Belém, PA, Brasil.
João Farias Guerreiro *Laboratório de Genética Humana e Médica, Instituto de Ciências Biológicas da Universidade Federal do Pará, Belém, PA, Brasil.
Antonio Carlos Rosário Vallinoto *Laboratório de Virologia, Instituto de Ciências Biológicas da Universidade Federal do Pará, Belém, PA, Brasil. vallinoto@ufpa.br.

Funding

Conselho Nacional de Desenvolvimento Científico e Tecnológico 301869/2017-0Conselho Nacional de Desenvolvimento Científico e Tecnológico 401235/2020-3Universidade Federal do Pará PAPQ-2020
6 · The paper itself

Abstract

The COVID-19 pandemic caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) reached the Brazilian Amazon and spread among indigenous populations. In the present study, we demonstrate a high prevalence of infection among the Xikrin of Bacajá people (Kayapó). A sample of 100 individuals of both sexes (51 men and 49 women) with ages ranging from 2 to 82 years were clinically evaluated and tested for the presence of anti-SARS-CoV-2 IgG antibody. Among all investigated individuals, 58 were IgG-reactive (58 %) by a rapid test, and 73 (73 %) were reactive in an enzyme-linked immunosorbent assay, with no difference between sexes. Oxygen saturation ranged from 82 to 99 %, with the lowest value observed in a two-year-old girl. The results show that as expected, SARS-CoV-2 infection rapidly reached more than 70 % of the population, most likely because of the difficulties of maintaining social distance due to cultural characteristics. These results highlight the importance of indigenous health policies as a means of minimizing the impact of the pandemic on these communities.

Indexed as

AdolescentAdultAgedAged, 80 and overAntibodies, ViralBrazilChildChild, PreschoolCOVID-19FemaleHumansImmunoglobulin GIndians, South AmericanMaleMiddle AgedPrevalenceAntibodies, ViralImmunoglobulin GAmazoniaCOVID-19Indigenous peoplesXikrin

Identifiers

PMID33509206
PMCPMC7841757

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.